SOX10 reactivity over time in nine patients during treatment follow up.

<p>DERMA and METRIC study treatment regimens are described under Methods.</p

Measurement of SOX10 via solid-phase PLA in sera from vitiligo patients (n = 85) and from controls (healthy blood donors) (n = 40).

<p>Mean Ct (y-axis) values of duplicate samples are shown. For statistical analyses 1-tail two sample heteroscedastic t-test was applied. *** P<0.001. Line indicates cut-off for samples calculated as positive.</p

Measurement of SOX10 via solid-phase PLA in sera from MM patients.

<p>Ct values in sera of 110 patients (in total 148 MM samples) (left) and 45 control sera samples (blood donors) (right). For statistical analyses 1-tail two sample heteroscedastic t-test was applied. * P< 0.05. Line indicates cut-off for samples calculated as positive.</p

Stages when 21 MM patients were found to be SOX10 positive.

<p>Stages when 21 MM patients were found to be SOX10 positive.</p

PLA-SOX10 vs. Cobas-s100 in 72 MM patients.

<p>PLA-SOX10 vs. Cobas-s100 in 72 MM patients.</p